A $58-million collaborative investment has propelled Canada into the global top five for DNA sequencing, enabling large-scale population studies and faster disease diagnosis. Author Debbie Lawes explores how this unified national platform integrates human and agricultural research to keep Canada at the forefront of personalized medicine and genomics innovation.